ResearcherKyoto Prefectural University of MedicineNo recent work listed
Mahito Miyamae
Matched on OpenAlex author ID A5076945956. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2015: 1 paper · 2016: 1 paper · 2017: 1 paper
Papers 3
- Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer. Co-author DOI 10.1038/s41598-017-06137-8↗
- Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids. Co-author DOI 10.3748/wjg.v22.i25.5627↗
- Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer. Co-author DOI 10.1038/bjc.2015.366↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Taisuke Imamura · 3 shared papers, 2015–2017 · strength 0.15
- Paper Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreati… DOI 10.1038/s41598-017-06137-8↗
- Paper Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids. DOI 10.3748/wjg.v22.i25.5627↗
- Paper Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer. DOI 10.1038/bjc.2015.366↗
- Ryo Morimura · 3 shared papers, 2015–2017 · strength 0.15
- Paper Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreati… DOI 10.1038/s41598-017-06137-8↗
- Paper Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids. DOI 10.3748/wjg.v22.i25.5627↗
- Paper Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer. DOI 10.1038/bjc.2015.366↗
- Daisuke Ichikawa · 3 shared papers, 2015–2017 · strength 0.15
- Paper Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreati… DOI 10.1038/s41598-017-06137-8↗
- Paper Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids. DOI 10.3748/wjg.v22.i25.5627↗
- Paper Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer. DOI 10.1038/bjc.2015.366↗
- Atsushi Shiozaki · 3 shared papers, 2015–2017 · strength 0.15
- Paper Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreati… DOI 10.1038/s41598-017-06137-8↗
- Paper Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids. DOI 10.3748/wjg.v22.i25.5627↗
- Paper Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer. DOI 10.1038/bjc.2015.366↗
- Eigo Otsuji · 3 shared papers, 2015–2017 · strength 0.15
- Paper Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreati… DOI 10.1038/s41598-017-06137-8↗
- Paper Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids. DOI 10.3748/wjg.v22.i25.5627↗
- Paper Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer. DOI 10.1038/bjc.2015.366↗
- Tsutomu Kawaguchi · 2 shared papers, 2015–2016 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.